An Observational Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Non-myeloid Malignancy

Epoetin Beta in Patients Undergoing Chemotherapy for Solid Tumors

NCT00875004 ·Status: TERMINATED ·Phase: NA

A Study of the Safety and Effectiveness of Epoetin Alfa on Hemoglobin Levels and Blood Transfusions in Cancer Patients Receiving Chemotherapy

NCT00216541 ·Status: COMPLETED ·Phase: PHASE4

Evaluating Treatment of Anemia in Subjects With Non-Myeloid MalignanciesReceiving Multicycle Chemotherapy

NCT00111462 ·Status: COMPLETED ·Phase: PHASE2

Anemia in Patients With a Non-Myeloid Malignancy

NCT00038064 ·Status: COMPLETED ·Phase: PHASE3

A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With a Non-Myeloid Malignancy

NCT00117624 ·Status: COMPLETED ·Phase: PHASE3

Treatment of Anemia in Patients With Cancer Who Are Not Currently Receiving Chemotherapy or Radiotherapy

NCT00083486 ·Status: TERMINATED ·Phase: PHASE3

A Safety Study of Epoetin Alfa in Patients With Cancer Who Have Chemotherapy-Related Anemia

NCT01394991 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in Patients With Anemia as a Result of Advanced Cancer and Treatment With Aggressive Chemotherapy

NCT00266617 ·Status: COMPLETED ·Phase: PHASE2

A Study of Darbepoetin Alfa in Anemic Subjects Not Receiving Chemotherapy Who Have Completed the 20010103 Study

NCT00115167 ·Status: COMPLETED ·Phase: PHASE3

Epoetin Alfa Biosimilar in the Management of Chemotherapy-Induced Symptomatic Anemia in Haematology and Oncology

NCT02140736 ·Status: COMPLETED

A Study of the Effectiveness and Safety of Treatment With Epoetin Alfa on Hemoglobin Levels, Red Blood Cell Transfusions, and Quality of Life in Patients With Cancer Receiving Platinum-containing Chemotherapy

NCT00283465 ·Status: COMPLETED ·Phase: PHASE4

Study for the Treatment of Anemia in Patients With Non-myeloid Malignancies Receiving Multicycle Chemotherapy.

NCT00148421 ·Status: COMPLETED ·Phase: PHASE3

Treatment for Patients With Non-Myeloid Malignancies Receiving Chemotherapy

NCT00111137 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Iron Supplementation During Darbepoetin Alfa Treatment in Prophylaxis of Severe Anaemia Chemo-Induced

NCT00210002 ·Status: TERMINATED ·Phase: PHASE2

Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy

NCT00003341 ·Status: COMPLETED ·Phase: PHASE3

Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy

NCT00003600 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess Symptom Burden in Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Aranesp®

NCT00117117 ·Status: COMPLETED ·Phase: PHASE4

Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy

NCT00110955 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Impact of Maintaining Hemoglobin Levels Using Epoetin Alfa in Patients With Metastatic Breast Cancer Receiving Chemotherapy

NCT00211133 ·Status: COMPLETED ·Phase: PHASE3

Chemotherapy Related Anemia

NCT00035607 ·Status: COMPLETED ·Phase: PHASE2

Study of Subcutaneously Administered Peginesatide in Anemic Cancer Patients Receiving Chemotherapy

NCT00272662 ·Status: COMPLETED ·Phase: PHASE2

Darbepoetin Alfa With or Without Intravenous (IV) Iron

NCT00401544 ·Status: COMPLETED ·Phase: PHASE2

Iron Replacement to Reduce Anemia During Neoadjuvant Chemotherapy

NCT05800600 ·Status: RECRUITING ·Phase: PHASE2

A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy

NCT00118638 ·Status: COMPLETED ·Phase: PHASE3

Dosing and Outcomes Study of Erythropoietic Stimulating Therapies in Patients With Chemotherapy Induced Anemia

NCT00212862 ·Status: COMPLETED